20120306
 Business and Finance   By Anonymous, The Wall Street Journal,  Mar 7, 2012  Authorities investigating the importation of low-cost foreign pharmaceuticals have identified a supply chain that may have allowed fake cancer drugs to reach U.S. clinics. ---   
